These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 708634)

  • 21. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
    Wormser GP; Keusch GT; Heel RC
    Drugs; 1982 Dec; 24(6):459-518. PubMed ID: 6759092
    [No Abstract]   [Full Text] [Related]  

  • 23. Co-trimoxazole induced diuresis.
    Tobin MJ; O'Connor P; FitzGerald MX
    Ir J Med Sci; 1982 Mar; 151(3):81-2. PubMed ID: 6978870
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of co-trimoxazole on serum creatinine.
    Dijkmans BA; van Hooff JP; de Wolff FA; Mattie H
    Br J Clin Pharmacol; 1981 Nov; 12(5):701-3. PubMed ID: 6977366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of biseptol for preventing the development of rifampicin-resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1988; (4):54-6. PubMed ID: 3138686
    [No Abstract]   [Full Text] [Related]  

  • 27. Increasing resistance of Neisseria gonorrhoeae to penicillin and co-trimoxazole--an in vitro study.
    Bhujwala RA; Pandhi RK; Singh OP; Shriniwas
    Indian J Med Res; 1980 Apr; 71():501-4. PubMed ID: 6771211
    [No Abstract]   [Full Text] [Related]  

  • 28. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro antibacterial effect of sulfamoxole/trimethoprim and sulfamethoxazole/trimethoprim].
    Hingst V; Sonntag HG
    Med Welt; 1979 Aug; 30(33):1199-201. PubMed ID: 491915
    [No Abstract]   [Full Text] [Related]  

  • 30. In-vitro susceptibility of organisms isolated from burns to topical co-trimoxazole.
    Holder IA
    J Antimicrob Chemother; 1981 Jun; 7(6):623-7. PubMed ID: 6972942
    [No Abstract]   [Full Text] [Related]  

  • 31. Improbability of selection for RIF resistance in Mycobacterium tuberculosis by accidental exposure during short-course therapy with Cotrifazid.
    Müller-Brundaler U; Dingfelder G; Urbanczik R
    Chemotherapy; 1997; 43(6):451-2. PubMed ID: 9395860
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problems in the testing of enterococcal resistance to trimethoprim-sulfamethoxazole].
    Tiesler E; Braun R
    Fortschr Med; 1976 Nov; 94(32):1885-9. PubMed ID: 825424
    [No Abstract]   [Full Text] [Related]  

  • 34. Trimethoprim-sulphamethoxazole-resistant Shigella dysenteriae serotype 1 (Shiga's bacillus) in Gimira, south-west Ethiopia.
    Gebre-Yohannes A; Belachew C
    Ethiop Med J; 1983 Oct; 21(4):275-6. PubMed ID: 6354711
    [No Abstract]   [Full Text] [Related]  

  • 35. Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection.
    Pearson NJ; Towner KJ; McSherry AM; Cattell WR; O'Grady F
    Lancet; 1979 Dec; 2(8154):1205-8. PubMed ID: 92620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing pattern of resistance to ampicillin and co-trimoxazole in Shigella serotypes in Bangalore, southern India.
    Macaden R; Bhat P
    J Infect Dis; 1985 Dec; 152(6):1348. PubMed ID: 3905991
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.
    Barker J; Healing D; Hutchison JG
    J Clin Pathol; 1972 Dec; 25(12):1086-8. PubMed ID: 4570620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Co-trimoxazole on renal creatinine excretion in man (author's transl)].
    Bräutigam M; Froese P; Baethke R; Kessel M
    Klin Wochenschr; 1979 Jan; 57(2):95-6. PubMed ID: 762950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
    Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
    Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.